載入...
Complex Decisions for First-Line and Maintenance Treatment of Advanced Wild-Type Non-Small Cell Lung Cancer
Until recently, the first-line treatment of advanced non-small cell lung cancer (NSCLC) required minimal clinical decision making. Patients who were eligible for chemotherapy received a platinum-based doublet, and 5-year survival rates were poor. With the advent of molecularly targeted agents and be...
Na minha lista:
| 發表在: | Oncologist |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AlphaMed Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4350796/ https://ncbi.nlm.nih.gov/pubmed/25660158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0212 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|